Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 7/20 | 0.37 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.34 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 3/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL30697434 | 1.00 | BBOX1 (0.41) | BBOX1LMNACYP3A4TSHRTDP1 | |
| Trifluoromethanesulfonic Acid SCHEMBL717623 | 0.98 | BBOX1 (0.40) | BBOX1LMNACYP3A4TSHRTDP1 | |
| Trifluoromethanesulfonic Acid SCHEMBL318063 | 0.98 | BBOX1 (0.40) | BBOX1LMNACYP3A4TSHRTDP1 | |
| Trifluoromethanesulfonic Acid SCHEMBL30331399 | 0.95 | LMNA (0.40) | BBOX1LMNACYP3A4TSHRTDP1 | |
| Trifluoromethanesulfonic Acid SCHEMBL1535096 | 0.93 | LMNA (0.42) | BBOX1LMNACYP3A4TSHRTDP1 | |
| Trifluoromethanesulfonic Acid SCHEMBL30330523 | 0.93 | LMNA (0.42) | BBOX1LMNACYP3A4TSHRTDP1 | |
| Trifluoromethanesulfonic Acid SCHEMBL3820014 | 0.93 | LMNA (0.42) | BBOX1LMNACYP3A4TSHRTDP1 | |
| Trifluoromethanesulfonic Acid SCHEMBL30330764 | 0.92 | LMNA (0.41) | BBOX1LMNACYP3A4TSHRTDP1 | |
| Trifluoromethanesulfonic Acid SCHEMBL4166764 | 0.92 | LMNA (0.41) | BBOX1LMNACYP3A4TSHRTDP1 | |
| Trifluoromethanesulfonic Acid SCHEMBL29252614 | 0.92 | LMNA (0.41) | BBOX1LMNACYP3A4TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 483 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026099153-A1 | DEVICE CAPABLE OF BONDING AND DEBONDING ON DEMAND | TESA SE (DE) | 2026-05-15 | — | — | WO | claimed |
| EP-4705295-A2 | MULTIFUNCTIONAL COMPOUND CORE FOR ACTIVE AGENTS AND USES THEREOF | The University of North Carolina at Chapel Hill (US) | 2026-03-11 | — | — | EP | claimed |
| US-20260015748-A1 | CHEMICALLY FACILITATED ELECTROCHEMICAL METHODS FOR RECOVERY OF RARE EARTH ELEMENTS | BATTELLE ENERGY ALLIANCE LLC (US) | 2026-01-15 | — | — | US | claimed |
| WO-2025108961-A1 | SOLID ELECTROLYTES AND METHOD FOR MANUFACTURING THE SAME | SOLITHOR (BE) | 2025-05-30 | — | — | WO | claimed |
| WO-2025104146-A1 | SOLID ELECTROLYTE SEPARATORS AND METHOD FOR MANUFACTURING THE SAME | SOLITHOR (BE) | 2025-05-22 | — | — | WO | claimed |
| WO-2025090284-A1 | ELECTROLYTE COMPRISING SOLVENT WITH NON-FLUORINE HALOGEN SUBSTITUTE AND BATTERIES COMPRISING SAME | FACTORIAL INC. (US) | 2025-05-01 | — | — | WO | claimed |
| WO-2025049222-A1 | ELECTROLYTE COMPRISING CYCLIC QUATERNARY AMMONIUM IONIC LIQUID AND SOLVENT WITH HIGH BOILING POINT AND BATTERIES COMPRISING SAME | FACTORIAL INC. (US) | 2025-03-06 | — | — | WO | claimed |
| US-12172147-B2 | Catalyst composition for selective hydrogenation with improved characteristics | Sud Chemie, Inc. (US) | 2024-12-24 | — | — | US | claimed |
| US-12172148-B2 | Catalyst composition for selective hydrogenation with improved characteristics | Sud Chemie, Inc. (US) | 2024-12-24 | — | — | US | claimed |
| US-12157287-B2 | Variable emissivity surfaces | THE UNIVERSITY OF MANCHESTER (GB) | 2024-12-03 | — | — | US | claimed |
| EP-1869061-A2 | ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY | Combimatrix Corporation (US) | 2007-12-26 | — | — | EP | claimed |
| US-20070181856-A1 | Conductive wet coating composition and thin-film prepared therefrom | SAMSUNG DISPLAY CO., LTD. (KR) | 2007-08-09 | — | — | US | claimed |
| US-20070176148-A1 | Organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2007-08-02 | — | — | US | claimed |
| EP-1805206-A2 | ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE | Combimatrix Corporation (US) | 2007-07-11 | — | — | EP | claimed |
| US-20070034513-A1 | Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array | COMBIMATRIX CORPORATION | 2007-02-15 | — | — | US | claimed |
| WO-2007006418-A1 | IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-01-18 | — | — | WO | claimed |
| WO-2006131234-A1 | COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-12-14 | — | — | WO | claimed |
| WO-2006105037-A2 | ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY | COMBIMATRIX CORPORATION (US) | 2006-10-05 | — | — | WO | claimed |
| WO-2006031814-A2 | ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE | COMBIMATRIX CORPORATION (US) | 2006-03-23 | — | — | WO | claimed |
| US-20060054511-A1 | Electrochemical deblocking using a hydrazine derivative | CUSTOMARRAY, INC. | 2006-03-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12172147-B2 | Catalyst composition for selective hydrogenation with improved characteristics | BET1, EP300, H1-2 | BBOX1 689/4885LMNA 3071/4885CYP3A4 1780/4885 |
| US-12172148-B2 | Catalyst composition for selective hydrogenation with improved characteristics | BET1, EP300, H1-2 | BBOX1 689/4885LMNA 3071/4885CYP3A4 1780/4885 |
| US-20260015748-A1 | CHEMICALLY FACILITATED ELECTROCHEMICAL METHODS FOR RECOVERY OF RARE EARTH ELEMENTS | RPS7, SRSF7, XPO7 | BBOX1 4542/4885LMNA 1492/4885CYP3A4 3652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.